New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
February 9, 2018 - Teva Pharmaceuticals launched an AB-rated generic version of Valeant’s Syprine (trientine) 250 mg capsules.
Download PDF
Return to publications
